Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

NASEM Biotechnology Regulatory FellowshipNASEM Biotechnology Regulatory Fellowship
VS
AmgenAmgen
NASEM Biotechnology Regulatory Fellowship

NASEM Biotechnology Regulatory Fellowship

N/A

Last Update: 09/06/2026

View Profile

Biotechnology Regulatory Fellowships are hands-on professional development fellowships structured to engage Fellows in developing the evidence basis needed to meet future regulatory challenges presented by novel products of biotechnology.

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Amgen

Amgen

One Amgen Center Drive, Thousand Oaks, 91320, US

Last Update: 11/09/2026

View Profile
Between 750 and 799
http://www.amgen.com
796/1000Fair

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human gene...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:39,128
Subsidiaries:4
12-month incidents
1
Known data breaches
2
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
NASEM Biotechnology Regulatory Fellowship

NASEM Biotechnology Regulatory Fellowship

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Amgen

Amgen

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for NASEM Biotechnology Regulatory Fellowship in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

Amgen has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - NASEM Biotechnology Regulatory Fellowship (X = Date, Y = Severity)

NASEM Biotechnology Regulatory Fellowship cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Amgen (X = Date, Y = Severity)

Amgen cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
NASEM Biotechnology Regulatory Fellowship

NASEM Biotechnology Regulatory Fellowship

Incidents
No explicit notable incidents reported.
Amgen

Amgen

Incidents
🔒 Incident : Breach
AMGCEN1785529893
🔒 Incident : Breach
AMG552072825

FAQ

Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has the best AI Cybersecurity Score ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced more cyber incidents in the past ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced more cyber incidents this year ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced at least one ransomware attack ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced at least one data breach ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced at least one targeted cyberattack ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has experienced at least one vulnerability ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one holds the most compliance certifications ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one holds the fewest compliance certifications ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has the most subsidiaries ?
Between NASEM Biotechnology Regulatory Fellowship company and Amgen company, which one has the largest number of employees ?
Between NASEM Biotechnology Regulatory Fellowship and Amgen, which company holds both SOC 2 Type 1 certifications ?
Between NASEM Biotechnology Regulatory Fellowship and Amgen, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - NASEM Biotechnology Regulatory Fellowship or Amgen ?
Which company is PCI DSS compliant - NASEM Biotechnology Regulatory Fellowship or Amgen ?
Between NASEM Biotechnology Regulatory Fellowship and Amgen, which company complies with HIPAA regulations for healthcare data ?
Between NASEM Biotechnology Regulatory Fellowship and Amgen, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-16174
SUMMARY

Netskope was notified about a potential gap in Netskope Endpoint DLP (EPDLP) running on Windows systems. Successful exploitation of the gap could potentially allow a privileged user to send a crafted message to the EPDLP process port to trigger an integer overflow, leading to memory corruption. Successful exploitation would require the EPDLP module to be enabled in the client configuration, and that Memory Integrity is disabled. A successful exploit could potentially result in a denial-of-service, arbitrary code execution, or privilege escalation on the local machine.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:P/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-16172
SUMMARY

Netskope was notified of an out-of-bounds heap read affecting the Endpoint DLP (EPDLP) service of the Netskope Client. A local standard user could potentially send a specially crafted message that is not properly validated with a bounds check, likely crashing the kernel driver handler. Successful exploitation could potentially crash the EPDLP service, temporarily interrupting DLP enforcement. A successful exploit could potentially also reveal per-boot memory layout information to unauthorized users.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.0
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-87958
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to a denial of service where a specific functionality on a Db2 server can be disabled by a privileged user under certain conditions.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86093
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.6
CVE-2026-86087
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an authenticated user to send a specially crafted request to write arbitrary files on the system.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8